Assuming 30 trading days horizon, Emisphere Technologies Inc. is expected to under-perform the Adamis. In addition to that, Emisphere is 1.14 times more volatile than Adamis Pharmaceuticals Corporation. It trades about -0.05 of its total potential returns per unit of risk. Adamis Pharmaceuticals Corporation is currently generating about -0.01 per unit of volatility. If you would invest 71.00 in Adamis Pharmaceuticals Corporation on April 26, 2012 and sell it today you would lose (6.00) from holding Adamis Pharmaceuticals Corporation or give up 8.45% of portfolio value over 30 days.
Diversification
Average diversification
Overlapping area represents amount of risk that can be diversified away by holding Emisphere Technologies Inc. and Adamis Pharmaceuticals Corp. in the same portfolio (assuming nothing else is changed)
Over the last 30 days Adamis Pharmaceuticals Corporation has generated negative risk-adjusted returns adding no value to investors with long positions.